Apoptosis-regulating pathways in cardiomyocytes

Apoptosis-regulating pathways in cardiomyocytes are the biochemical signaling cascades that control programmed cell death within heart muscle cells (Whelan et al., 2010, PMID: 20179712). These pathways are broadly categorized into the intrinsic (mitochondrial) pathway, the extrinsic (death receptor) pathway, and the endoplasmic reticulum (ER) stress-induced pathway (Lee et al., 2012, PMID: 22461127). In the healthy heart, apoptosis is a rare event, but it is significantly upregulated during pathological conditions such as myocardial infarction, ischemia-reperfusion injury, and chronic heart failure (Abbeele et al., 2005, PMID: 15618305). The loss of cardiomyocytes through these pathways leads to ventricular remodeling, fibrosis, and a progressive decline in cardiac function. Therapeutic interventions often focus on modulating specific components of these pathways, such as inhibiting pro-apoptotic BCL-2 family members or caspases, to preserve myocardial tissue (Garrido et al., 2006, PMID: 16461340). For instance, drugs like Carvedilol have been shown to exert anti-apoptotic effects by modulating mitochondrial function and reducing oxidative stress (Yue et al., 1998, PMID: 9591757). However, because these pathways are fundamental to cell turnover in other tissues, achieving cardiac-specific modulation remains a significant pharmacological challenge. The risk of systemic toxicity or oncogenesis necessitates the development of targeted delivery systems or highly selective molecular inhibitors.

Other names

Cardiomyocyte apoptosisProgrammed cell death in heart cellsCardiac apoptotic signaling cascades

Modulation of pro-apoptotic and anti-apoptotic signaling cascades, including the inhibition of caspases, stabilization of mitochondrial membranes, and activation of pro-survival kinases like Akt (Lee et al., 2012, PMID: 22461127).